436 related articles for article (PubMed ID: 18957531)
1. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 levels are independently associated with albuminuria in type 2 diabetes.
Røndbjerg AK; Omerovic E; Vestergaard H
Cardiovasc Diabetol; 2011 Jun; 10():54. PubMed ID: 21696606
[TBL] [Abstract][Full Text] [Related]
3. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
[TBL] [Abstract][Full Text] [Related]
4. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.
Sakamoto F; Katakami N; Kaneto H; Yasuda T; Takahara M; Miyashita K; Kuroda A; Matsuhisa M; Kosugi K; Shimomura I
Endocr J; 2013; 60(1):73-9. PubMed ID: 22986489
[TBL] [Abstract][Full Text] [Related]
5. Correlation between serum YKL-40 levels and albuminuria in type 2 diabetes.
Han JY; Ma XY; Yu LJ; Shao Y; Wang QY
Genet Mol Res; 2015 Dec; 14(4):18596-603. PubMed ID: 26782508
[TBL] [Abstract][Full Text] [Related]
6. High YKL-40 levels predict mortality in patients with type 2 diabetes.
Persson F; Rathcke CN; Gall MA; Parving HH; Vestergaard H; Rossing P
Diabetes Res Clin Pract; 2012 Apr; 96(1):84-9. PubMed ID: 22209020
[TBL] [Abstract][Full Text] [Related]
7. Plasma YKL-40 levels are elevated in patients with chronic heart failure.
Rathcke CN; Kistorp C; Raymond I; Hildebrandt P; Gustafsson F; Lip GY; Faber J; Vestergaard H
Scand Cardiovasc J; 2010 Apr; 44(2):92-9. PubMed ID: 19961288
[TBL] [Abstract][Full Text] [Related]
8. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
[TBL] [Abstract][Full Text] [Related]
9. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
Rathcke CN; Raymond I; Kistorp C; Hildebrandt P; Faber J; Vestergaard H
Int J Cardiol; 2010 Aug; 143(1):35-42. PubMed ID: 19223085
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.
Lee JH; Kim SS; Kim IJ; Song SH; Kim YK; In Kim J; Jeon YK; Kim BH; Kwak IS
J Diabetes Complications; 2012; 26(4):308-12. PubMed ID: 22705282
[TBL] [Abstract][Full Text] [Related]
12. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
Żurawska-Płaksej E; Ługowska A; Hetmańczyk K; Knapik-Kordecka M; Adamiec R; Piwowar A
Biomarkers; 2015 Feb; 20(1):52-7. PubMed ID: 25519006
[TBL] [Abstract][Full Text] [Related]
13. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
[TBL] [Abstract][Full Text] [Related]
14. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
[TBL] [Abstract][Full Text] [Related]
15. YKL-40--an emerging biomarker in cardiovascular disease and diabetes.
Rathcke CN; Vestergaard H
Cardiovasc Diabetol; 2009 Nov; 8():61. PubMed ID: 19930630
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
Wang ST; Xu JM; Wang M; Chen FL; Ding G
Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
[TBL] [Abstract][Full Text] [Related]
17. YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.
Yasuda T; Kaneto H; Katakami N; Kuroda A; Matsuoka TA; Yamasaki Y; Matsuhisa M; Shimomura I
Diabetes Res Clin Pract; 2011 Feb; 91(2):e50-2. PubMed ID: 21159401
[TBL] [Abstract][Full Text] [Related]
18. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
19. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
Elsamahy MH; Elhenawy YI; Nawar MM
J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
